ImmunoGen, Inc.·4

Sep 19, 5:39 PM ET

White Lauren 4

4 · ImmunoGen, Inc. · Filed Sep 19, 2023

Insider Transaction Report

Form 4
Period: 2023-09-18
White Lauren
SVP, CFO AND PFO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-09-18+295,975295,975 total
    Exercise: $15.71Exp: 2033-09-18Common Stock (295,975 underlying)
  • Award

    Restricted Stock Unit

    2023-09-18+51,62551,625 total
    Exercise: $0.00Common Stock (51,625 underlying)
Footnotes (3)
  • [F1]These options vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant, subject to continued service through each vesting date.
  • [F2]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
  • [F3]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each of the first four anniversaries of the date of grant, subject to continued service through each vesting date.

Documents

1 file
  • 4
    form4-09192023_090937.xmlPrimary